We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-1.20 | -1.12% | 106.07 | 106.92 | 105.895 | 106.92 | 5,072,972 | 22:14:13 |
In accordance with the amended regulations not to require issuers of shares listed on Oslo Axess to produce and publish quarterly reports, Aqua Bio Technology ASA has today resolved that the company going forward will publish financial information by producing half-yearly report and annual report. Consequently, the company will no longer produce and publish quarterly financial information.
On this basis, the company has updated its financial calendar.
Updated financial calendar for Aqua Bio Technology ASA is as follows:
FINANCIAL YEAR 2016
Annual report 2016 - 19.04.2017
FINANCIAL YEAR 2017
Half-yearly report - 16.08.2017
Annual general meeting 2017 - 07.06.2017
This information is published pursuant to the requirements set out in the Continuing obligations.
For further information, please call Arvid Lindberg, CEO, telephone +47 9824 5410
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on the Axess market of the Oslo Stock Exchange.
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions